Keros Therapeutics, Inc.KROSNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
76.28%
↑ 862% above average
Average (26q)
-10.01%
Historical baseline
Range
High:422.54%
Low:-332.28%
Volatility
-7539.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 76.28% |
| Q2 2025 | -120.68% |
| Q1 2025 | 422.54% |
| Q4 2024 | 13.09% |
| Q3 2024 | -17.01% |
| Q2 2024 | -4.97% |
| Q1 2024 | -7.13% |
| Q4 2023 | -2.04% |
| Q3 2023 | -5.16% |
| Q2 2023 | -4.75% |
| Q1 2023 | -20.48% |
| Q4 2022 | -26.41% |
| Q3 2022 | 13.78% |
| Q2 2022 | -12.73% |
| Q1 2022 | -248.50% |
| Q4 2021 | 65.81% |
| Q3 2021 | -29.93% |
| Q2 2021 | 1.66% |
| Q1 2021 | -48.79% |
| Q4 2020 | 11.30% |
| Q3 2020 | -11.89% |
| Q2 2020 | 9.54% |
| Q1 2020 | -332.28% |
| Q4 2019 | 22.49% |
| Q3 2019 | -24.40% |
| Q2 2019 | 10.37% |
| Q1 2019 | 0.00% |